Chondritis of the ear after docetaxel-carboplatin chemotherapy.
Chondritis
docetaxel
ear
side effect
Journal
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
ISSN: 1477-092X
Titre abrégé: J Oncol Pharm Pract
Pays: England
ID NLM: 9511372
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
pubmed:
29
3
2018
medline:
8
6
2019
entrez:
29
3
2018
Statut:
ppublish
Résumé
Docetaxel, derived from the yew tree, belongs to the taxane family of medications. It works by disrupting the normal function of microtubules, thereby stopping cell division. Docetaxel is used in the treatment of ovarian, breast, esophageal, gastric, prostate, lung, and head and neck cancers. Common side effects include hair loss, low blood cell counts, peripheral neuropathy, vomiting, and muscle pain. Auricular chondritis with ear deformity has not been reported previously as a side effect of docetaxel. In this paper, we present the case of a 64-year-old male patient with chondritis accompanied by ear deformity that developed due to docetaxel-carboplatin chemotherapy for non-small cell lung cancer.
Identifiants
pubmed: 29587605
doi: 10.1177/1078155218762629
doi:
Substances chimiques
Docetaxel
15H5577CQD
Carboplatin
BG3F62OND5
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM